Keeping you connected to your loved ones during emergencies
Embrace2 is the only FDA-cleared wrist-worn wearable in epilepsy. It detects possible convulsive seizures and instantly alerts caregivers, whether they're sleeping next door or are living miles away. Created to offer round-the-clock safety and comfort, to help people with epilepsy get help when they need it most.
Cleared by the FDA for adults and children ages 6 and up
48h+ Battery Life
Always on the lookout.
48h+ of battery life to keep you covered day and night
Never leaves your side.
A quick 30 min charge powers up a full day
Discreet and stylish.
For a comfortable and personalized look
The highest accuracy in the field
Embrace2 has the highest accuracy of all at-home, wearable consumer devices for epilepsy, making it the most reliable option for seizure alerting around-the-clock 1, 2, 3, 4. With its unique rest mode, Embrace is optimized to detect any possible convulsive seizures during sleep or periods of rest with practically no disruptions 5.
Light & Small
Embrace weighs 13 grams, as much as two sheets of paper.
Embrace transmits data to a paired smartphone via Bluetooth connection.
Embrace is water-resistant for up to 1m/3ft.
Embrace is packed with four powerful sensors: Electrodermal Activity, Temperature, Accelerometer, Gyroscope.
On getting your prescription
As an FDA-cleared medical device, Embrace2 requires a valid prescription from your healthcare practitioner. Due to the COVID-19 emergency, and to assure that you can still benefit from Embrace and Alert without leaving your home, you will now be able to purchase and receive Embrace2 without the immediate need of uploading your prescription, having 120 extra days to provide us with one.
Embrace2 is for adults and children (FDA-cleared for ages 6 and up). For use with children under 6, we recommend that you consult your doctor. Embrace is designed to detect possible generalized tonic-clonic seizures lasting longer than 20 seconds. Other non-convulsive seizure types currently cannot be detected by Embrace2.
What does Embrace2 do?
When Embrace2 detects a possible tonic-clonic seizure, it communicates with its companion app Alert on its paired mobile device to alert your caregivers with a phone call and text message. Embrace2 does not predict seizures. It is designed to expedite assistance when a seizure occurs. To learn more about how Embrace2 works, watch our animated video.
What do I need for Embrace2 to work?
The person wearing Embrace will need two things: a compatible mobile device with a stable internet connection and the Alert App with an active subscription plan. Remember, the person wearing Embrace2 needs the connected mobile device within a 30ft radius at all times, but alerts can be sent to caregivers at any location.
How can I buy Embrace2?
Embrace2 is available worldwide and can be purchased only on our online store starting from $249. Keep in mind that Embrace2 is an FDA-cleared medical device and requires a valid prescription from a healthcare provider. Upon purchase, you will have 120 days to provide us with the prescription. Payments with FSA/HSA cards are also accepted.
Thinking of applying for insurance reimbursement? We’re here to help!
Embrace might be eligible for reimbursement by your insurance company. Getting it reimbursed depends on your specific plan and service provider, but we’re here to help you get started with the process.
Ask your doctor to fill this predetermination form, then either you or your doctor can submit it to your insurance provider to improve your chances of reimbursement.
*Battery performance is subject to variability and might degrade over time.
We do not guarantee that Embrace and the Alert App will detect every single seizure and deliver alerts accordingly. They are not meant to substitute your current seizure monitoring practices, but rather to serve as a supplement in expediting first-response time.
Embrace is currently available only in English. Embrace is an investigational device in the USA and a medical device in the EU. If you do not see your country listed, please visit the International site.